Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.
Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.
The two monoclonal antibodies currently approved for treatment in patients with multiple myeloma are elotuzumab and daratumumab. While infusion reactions can occur with these treatments, there are pre-medications recommended. Additionally, most reactions are not usually experienced beyond the first infusion.
To learn more about these treatments, watch Safety of Monoclonal Antibodies in Myeloma.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.